Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 137 of the 140 references it cites were found in a registry or an index.

Tumor Cell Dormancy: Threat or Opportunity in the Fight against Cancer

Open access
Jahanban-Esfahlan, Rana, Seidi, Khaled, Manjili, Masoud H., Jahanban-Esfahlan, Ali, Javaheri, Tahereh, Zare, Peyman · 2019 · Cancers

Abstract

Tumor dormancy, a clinically undetectable state of cancer, makes a major contribution to the development of multidrug resistance (MDR), minimum residual disease (MRD), tumor outgrowth, cancer relapse, and metastasis. Despite its high incidence, the whole picture of dormancy-regulated molecular programs is far from clear. That is, it is unknown when and which dormant cells will resume proliferation causing late relapse, and which will remain asymptomatic and harmless to their hosts. Thus, identification of dormancy-related culprits and understanding their roles can help predict cancer prognosis and may increase the probability of timely therapeutic intervention for the desired outcome. Here, we provide a comprehensive review of the dormancy-dictated molecular mechanisms, including angiogenic switch, immune escape, cancer stem cells, extracellular matrix (ECM) remodeling, metabolic reprogramming, miRNAs, epigenetic modifications, and stress-induced p38 signaling pathways. Further, we analyze the possibility of leveraging these dormancy-related molecular cues to outmaneuver cancer and discuss the implications of such approaches in cancer treatment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/cancers11081207

Cites

137 of 137 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 The implication of the immune system in tumor cell dormancy.
Figure 1 The implication of the immune system in tumor cell dormancy.CC BY · PubMed Central
Figure 2 The implication of ECM and p38 signaling in tumor dormancy.
Figure 2 The implication of ECM and p38 signaling in tumor dormancy.CC BY · PubMed Central
Figure 3 Tumor dormancy as a therapeutic opportunity to fight cancer back.
Figure 3 Tumor dormancy as a therapeutic opportunity to fight cancer back.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

2 retracted

Show all 140 references

Cited by

See all 111

Metadata

Authors
Jahanban-Esfahlan, R., Seidi, K., Manjili, M. H., Jahanban-Esfahlan, A., Javaheri, T., & Zare, P.
Affiliations
  • Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz 9841, Iran
  • Tabriz University of Medical Sciences (IR)
  • Virginia Commonwealth University (US)
  • Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz 9841, Iran
  • Ludwig Boltzmann Institute for Cancer Research (AT)
  • Faculty of Medicine, Cardinal Stefan Wyszyński University in Warsaw, 01-938 Warsaw, Poland
Corresponding author
Javaheri, Tahereh
Venue
Cancers
Publisher
MDPI AG
Published
2019-08-19
Volume
11
Issue
8
Pages
1207
ISSN
2072-6694 (ISSN-L)
OpenAlex
W2897235350
Cited by
111
References
140
Citations by year
2026: 8 · 2025: 16 · 2024: 7 · 2023: 13 · 2022: 19 · 2021: 21 · 2020: 25 · 2019: 1
FWCI
1.57
Type
journal article
Language
en
Open access
Locations
  • Cancers (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
  • Physical Sciences › Mathematics › Modeling and Simulation › Mathematical Biology Tumor Growth
Keywords
tumor dormancy, tumor recurrence, metastasis, multidrug resistance, minimal residual disease, angiogenic switch, immune evasion, cancer stem cells, extracellular matrix remodeling, metabolic reprogramming, microRNA, epigenetic modifications, p38 signaling, cancer prognosis, cancer therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Tumor Cell Dormancy: Threat or Opportunity in the Fight against Cancer. https://app.cochat.ai/papers/10.3390/cancers11081207
The paper
Jahanban-Esfahlan, R., Seidi, K., Manjili, M. H., Jahanban-Esfahlan, A., Javaheri, T., & Zare, P. (2019). Tumor Cell Dormancy: Threat or Opportunity in the Fight against Cancer. Cancers. https://doi.org/10.3390/cancers11081207

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.